Article
Targeted therapies for cutaneous melanoma.
Hematology/oncology clinics of North America - 1 Jun 2014
Kee Damien, McArthur Grant
Abstract excerpt
Melanoma is resistant to cytotoxic therapy, and treatment options for advanced disease have been limited historically. However, improved understanding of melanoma driver mutations, particularly those involving the mitogen-activated protein kinase pathway, has led to the development of targeted th...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
